Case Study: A Rapid Rollout of Universal Maternal HAART Improves Outcomes among HIV-Positive Women and Their Infants in Kenya.

Autor: Muganda M; Jhpiego, APHIAPLUSKAMILI, Embu, Kenya., Njogu R; Jhpiego, APHIAPLUSKAMILI, Embu, Kenya., Mutwiwa S; Jhpiego, Embu, Kenya., Kiraithe L; Ministry of Health, Tharaka Nithi, Kenya., Munyi E; County AIDS Coordinator, Ministry of Health, Tharaka Nithi, Kenya., Mulase L; Jhpiego/APHIAPLUSKAMILI, Embu, Kenya., Bii S; Agreement Officer Representative, USAID, Nairobi, Kenya., Mudany M; Country Director, Chief of Party, Jhpiego, Nairobi, Kenya.
Jazyk: angličtina
Zdroj: World health & population [World Health Popul] 2015; Vol. 16 (2), pp. 24-30.
DOI: 10.12927/whp.2016.24496
Abstrakt: Globally, countries have made significant achievements in reducing rates of mother-to-child transmission (MTCT) of HIV. In Kenya, MTCT rates were most recently estimated at 8%, with 220,000 children under 15 years of age living with HIV. In 2013, the World Health Organization recommended highly active antiretroviral therapy (HAART) for all HIV-infected pregnant and lactating women. APHIAPLUSKAMILI supported rollout of a county-level, targeted, rapid scale-up of HAART in 152 high-volume facilities in Kenya. A review and comparison of data from these facilities in 2013 and 2014 revealed a significant increase in the proportion of women started on HAART and a reduction in MTCT.
Databáze: MEDLINE